Enrolling Now

Enrolling Now

Medication for Nocturnal Hypoglycemia

  • A study of the effect of novel medication on the frequency of nocturnal hypoglycemia in Type 1 Diabetes.

    • Aged between 18 and 75 years with immune-mediated Type 1 Diabetes for at least 5 years,

    • Receiving multiple daily injections of insulin or continuous subcutaneous insulin infusion as your only Type 1 Diabetes therapy.

    • Recent history suggesting risk of nocturnal hypoglycemia (as indicated by TBR54 of ≥1%)

  • Gain access to cutting-edge medications and treatments before they are widely available.

    Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.

    We are highly focused on patient well-being and the highest ethical standards in clinical research.

A young man with brown hair sleeping peacefully on a bed, with his arm extended and eyes closed.

This study is run from our Long Island City office (36-36 33rd Street, Queens).

Think you may qualify? Fill out this form and a member of our medical research team will be in touch shortly with more information.